Domača stranMDT • NYSE
add
Medtronic
Prejšnji trg. dan.
82,68 $
Dnevni razpon
80,51 $ - 82,49 $
Letni razpon
75,96 $ - 92,68 $
Tržna kapitalizacija
103,43 mrd. USD
Povprečni obseg
6,11 mio.
Razm. P/E
24,61
Dividendna donosnost
3,47 %
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(USD) | okt. 2024info | Sprememba L/L |
---|---|---|
Prihodek | 8,40 mrd. | 5,25 % |
Stroški poslovanja | 3,78 mrd. | 2,30 % |
Čisti dohodek | 1,27 mrd. | 39,71 % |
Čista dobičkovnost prihodkov | 15,11 | 32,66 % |
Earnings per share | 1,26 | 0,80 % |
EBITDA | 2,36 mrd. | 6,70 % |
Efektivna davčna stopnja | 18,01 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(USD) | okt. 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 7,99 mrd. | 3,30 % |
Skupna sredstva | 90,04 mrd. | −0,05 % |
Skupne obveznosti | 41,33 mrd. | 7,51 % |
Celoten lastniški kapital | 48,72 mrd. | — |
Shares outstanding | 1,28 mrd. | — |
Razmerje P/B | 2,19 | — |
Donosnost sredstev | 4,68 % | — |
Donosnost kapitala | 5,50 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(USD) | okt. 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | 1,27 mrd. | 39,71 % |
Denar iz dejavnosti | 958,00 mio. | 44,93 % |
Denar iz naložb | −345,00 mio. | 18,63 % |
Denar iz financiranja | −534,00 mio. | −493,33 % |
Neto sprememba denarnih sredstev | 83,00 mio. | 396,43 % |
Prost denarni tok | 748,25 mio. | 16,23 % |
Vizitka
Medtronic plc is an American-Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue.
Medtronic's pioneering innovations have transformed healthcare through ground-breaking medical devices. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter defibrillator, and remote monitoring systems. They also created breakthrough solutions in diabetes care with the first 24-hour automated insulin delivery, deep brain stimulation, and miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
Generalni direktor
Datum ustanovitve
1949
Spletno mesto
Zaposleni
95.000